Citigroup venture wing might offload Turkish drugmaker
Citigroup Venture Capital International and fellow investor Partners in Life Sciences are believed to be interested in selling their stake in Turkish copycat drugmaker Biofarma, according to Reuters. The pair bought Biofarma for $200 million in 2007 and later sold a stake to Global Finance, a Greek private equity firm. Biofarma has met with investment bankers and advisors, with valuations of the company ranging from $500 million to $1 billion.
12 October 2010•1 min read
